PASSAGE BIO, INC. Public Float
PASSAGE BIO, INC. (PASG) had Public Float of $25.40 million as of 2025-06-30, per its 10-K filed 2026-03-03.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-03
- 2025-06-30: Entity Public Float $25.40M.
- 2024-06-28: Entity Public Float $48.90M.
- 2023-06-30: Entity Public Float $46.80M.
- 2022-06-30: Entity Public Float $100.60M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $25.40M 10-K · filed 2026-03-03 |
| 2024-06-28 | $48.90M 10-K · filed 2025-03-04 |
| 2023-06-30 | $46.80M 10-K · filed 2024-03-04 |
| 2022-06-30 | $100.60M 10-K · filed 2023-03-06 |
| 2021-06-30 | $483.30M 10-K · filed 2022-03-03 |
| 2020-06-30 | $771.50M 10-K · filed 2021-03-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| BioCardia, Inc. (BCDA) | United States | $0.016B | |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |